INDIANAPOLIS, January 31,2018 /PRNewswire/ -- - Fourth-quarter 2017 revenue increased 7 percent, driven primarily by volume growth from new pharmaceutical products, while operating expenses remained flat. - Fourth-quarter 2017 earnings per share (EPS) reflected a loss of $1.58 on...
from PR Newswire: //http://ift.tt/2DS2Fc0
No comments:
Post a Comment